NEW DELHI: The government announced Wednesday that people over 60 and those over 45 with comorbidities will be able to receive Covid-19 vaccines starting March 1. At a press conference, Union Minister Prakash Javadekar said that the vaccines will be free at some 10,000 government centers throughout the country. The …
Read More »
India’s drug regulator has approved the Oxford Covid-19 Covishield vaccine, manufactured by the Serum Institute of India (SII), and the indigenously developed Bharat Biotech Covaxin. Stock Market News Today | Sensex, Nifty, stock prices LIVE: National stock benchmarks were trading at a profit on Monday. S&P BSE Sensex rose more …
Read More »
The Controller General of Drugs of India (DCGI) VG Somani reassured people on Sunday about the safety of the two Covid-19 vaccines from Bharat Biotech and Oxford-AstraZeneca when giving final approval for the injections. Somani made the formal announcement approving the Oxford-AstraZeneca vaccine manufactured by the Serum Institute of India …
Read More »
For the executive director of the Serum Institute of India, Adar Poonawalla, the moment of happy new year came on January 3 after the General Controller of Drugs of India on Sunday gave the final go-ahead to Covishield, the vaccine developed by the Oxford University and leading pharmaceutical Astrazeneca and …
Read More »
The Government of India has granted approval in principle to two vaccines against Coronavirus, setting the stage for the deployment of the first phase of mass vaccination in the country. The Subject Matter Expert Committee (SEC) of the Central Organization for the Control of Medicines Standards recommended the granting of …
Read More »
NEW DELHI: A day before the nationwide Covid-19 vaccination trial, the Indian drug regulator’s expert panel on Friday cleared the platforms for emergency use authorization for the vaccine developed by AstraZeneca and the University from Oxford. The vaccine, which is being produced locally under the name Covishield by the Serum …
Read More »
NEW DELHI: The Serum Institute of India said on Monday it has already produced nearly 50 million doses of the Oxford-AstraZeneca Covid-19 vaccine and awaits emergency use approval from Indian and UK regulators in the ” next days”. “You will hear good news from the UK very soon,” Serum CEO …
Read More »
HYDERABAD: India’s first indigenous Covid-19 vaccine, Covaxin, has shown long-term antibody and T-cell memory responses three months after vaccination in phase I volunteers Covaxin can generate antibodies that can persist for 6 to 12 months, Bharat Biotech said in a research article. According to the document uploaded to ‘medRxiv’, a …
Read More »
NEW DELHI: The Center on Monday released detailed guidelines for India’s mass vaccination campaign that will begin once the lead candidates, some of whom are under regulatory review, are available for emergency use. In phase one of the vaccination campaign, the government plans to vaccinate nearly 30 million people, including …
Read More »
NEW DELHI: With at least three candidate vaccines under regulatory review for emergency use, India has begun preparing for a mega vaccination campaign to immunize millions of vulnerable people in the next six to eight months. The government has said it will deploy its vast electoral machinery to deliver 60 …
Read More »